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ABSTRACT 
 
Intraflagellar transport (IFT), the key mechanism for ciliogenesis, involves large 
protein particles moving bi-directionally along the entire ciliary length. IFT particles 
contain two large protein complexes, A and B, which are constructed with proteins in a 
core and several peripheral proteins. Prior studies have shown that in Chlamydomonas 
reinhardtii, IFT46, IFT52, and IFT88 directly interact with each other and are in a 
subcomplex of the IFT B core. However, ift46, bld1, and ift88 mutants differ in 
phenotype as ift46 mutants are able to form short flagella, while the other two lack 
flagella completely. In this study, we investigated the functional differences of these 
individual IFT proteins contributing to complex B assembly, stability, and basal body 
localization. We found that complex B is completely disrupted in bld1 mutant, indicating 
an essential role of IFT52 for complex B core assembly. Ift46 mutant cells are capable of 
assembling a relatively intact but highly unstable complex B. In contrast, in ift88 mutant 
cells the complex B core still assembles and remains stable, but the peripheral proteins 
no longer attach to the B core. Moreover, while complex A and the anterograde IFT 
motor FLA10 are localized normally to the transition fibers, complex B proteins instead 
are accumulated at the proximal ends of the basal bodies in ift88. Taken together, these 
results revealed a step-wise assembly process for complex B, and showed that the 
complex first localizes to the proximal end of the centrioles and then translocates onto 
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the transition fibers via an IFT88-dependent mechanism. Protein interaction analyses 
such as the yeast two-hybrid assay in addition to identification and characterization of 
novel IFT complex B mutants will reveal a more complete picture of the architecture and 
function of IFT complex B.   
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NOMENCLATURE 
 
IFT Intraflagellar transport 
RESDA Restriction enzyme site-directed amplification 
PCR Polymerase chain reaction 
LB Luria-Bertani (Broth medium) 
TAP Tris-acetate-phosphate medium 
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CHAPTER I 
 INTRODUCTION * 
 
Background 
Cilia and flagella are hair-like organelles extending from the basal bodies of 
almost all eukaryotic cells. These cellular appendages play important roles for cellular 
homeostasis and development. Failure to build or maintain functioning cilia leads to a 
wide spectrum of human diseases and disorders collectively known as ciliopathies, 
which include hydrocephalus, polycystic kidney disease, primary ciliary dyskinesia, 
Bardet Biedl Syndrome, etc [1,2]. 
The assembly and function of the flagella rely on intraflagellar transport (IFT), 
the conserved bi-directional movement of linear trains of IFT particles along the 
axoneme [3]. The IFT particle is composed of two complexes, A and B, which play 
overlapping yet distinct functions for the traffic of IFT. Complex B is essential for the 
anterograde IFT, while complex A appears to mediate the retrograde movement [4-8]. 
There are at least 6 subunits in complex A and 13 in complex B [9,10]. In 
Chlamydomonas, both IFT A and B complexes contain a core complex and several 
peripheral proteins (Figure 1). The complex A core refers to the smaller complex found 
                                                 
* Reprinted with permission from “Dissecting the Sequential Assembly and Localization of Intraflagellar 
Transport Particle Complex B in Chlamydomonas” by Richey EA, Qin H, 2012. PLoS ONE, 7(8): e43118. 
doi:10.1371/journal.pone.0043118, Copyright [2012] by Elizabeth Richey. 
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in a complex A mutant ift121 [11]. The complex B core is an 11S complex that stays 
intact in high ionic conditions [12].  
Current Knowledge of IFT Complex B 
Using the E. coli co-expression system, previous studies have revealed that the 
complex B core contains at least two tetrameric subcomplexes IFT81/74/27/25 and 
IFT88/70/52/46 [13]. IFT52 was suggested to bridge the two tetramers since it directly 
interacts with IFT81/74/27/25 [13]. IFT27/25 and IFT81/74 form two stable dimer 
complexes [12,14,15]. The IFT88/70/52/46 tetramer contains many strong interactions. 
IFT52, IFT46, and IFT88 interact with each other [13,16], while IFT52 and IFT46 also 
interact with IFT70 [13,17]. Pair-wise interaction assays have provided some detailed 
information as to the structure of the complex B core. However, little is known as to how 
the interactions among the subcomplexes contribute to the in vivo assembly of the 
functional complex B.  
Figure 1. Architecture of IFT Complex B in wild type Chlamydomonas reinhardtii. 
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To date, many IFT protein mutants have been identified in various organisms. 
These mutants all have defects in ciliogenesis. However, the severity of such defects 
varies among the mutants. For example, in Caenorhabditis elegans, the cilia of osm-
6/ift52 and osm-5/ift88 mutants are highly stunted with no ciliary axonemal microtubules 
beyond the transition zone [18]. In contrast, dyf-6/ift46 [19], dyf-1/ift70 [20], ift74, and 
ift81 [21,22] mutants are capable of assembling the middle segment of the chemosensory 
amphid and phasmid cilia, and IFT motility is intact in the remaining cilia. So far, the 
function of IFT88 has been studied in many different species. The IFT88 mutants of 
Chlamydomonas [23], Drosophila [24], and mouse [25] are all incapable of assembling 
cilia, demonstrating that IFT88 plays an essential and conserved role in ciliogenesis. The 
Chlamydomonas mutant of IFT52, bld1, is completely flagella-less [26], which is 
consistent with the phenotype seen in C. elegans. The Chlamydomonas ift46 mutant [27] 
and the Tetrahymena dyf-1/ift70 [28] mutant have very short flagella with severely 
disrupted axonemal structures. The fact that neither dyf-6/ift46 nor dyf-1/ift70 are 
completely flagella-less indicates IFT46 and IFT70 do not completely abrogate IFT and 
ciliogenesis.  
Research Objectives and Study Approach 
Chlamydomonas IFT46, IFT52 and IFT88 are in the same subcomplex of the IFT 
B core and can form a stable trimetric complex [16]. Multiple interactions have been 
found among these three subunits, thus it was expected that deletion of any of the 
components would destroy the entire complex, and stop IFT. However, their mutants 
differ in phenotype as ift46 mutants are able to form short flagella [27], while the other 
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two mutants lack flagella completely [23,26] (Figure 2). This led us to ask, what are the 
different roles that IFT46, IFT52, and IFT88 play in IFT, and how can these differences  
 
  
  
 
 
 
lead to presence or absence of flagella in these mutants? To answer these questions, the 
research objectives are as follows:  
1. Determine the assembly status of complex B in ift46, bld1, and ift88 mutants. 
Sucrose density gradients were utilized to identify which proteins cosedimented, and 
therefore were likely to be in complex with each other. This made it possible to conclude 
the level of complex B disruption in each mutant, leading to a more clear understanding 
of how IFTs 46, 52, and 88 are important in complex B assembly.   
2. Analyze stability of IFT and motor proteins in ift46, bld1, and ift88 mutants. 
Cell cultures were treated with cycloheximide, a protein synthesis inhibitor, and samples 
were taken throughout a time course.  This assay demonstrated the relationships between 
Fl
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Wild Type ift46 bld1 ift88
Figure 2.  Phenotypes of wild type, ift46, bld1, and ift88.  Compared to 
wild type, ift46 is able to produce stumpy flagella, while bld1 and ift88 are 
unable to produce flagella. 
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IFTs 46, 52, and 88 with the stabilities and turnover rates of other IFT and motor 
proteins.  
3. Identify the localization patterns of IFT proteins in ift46, bld1, and ift88 
mutants. Immunofluorescent staining revealed the importance of IFTs 46, 52, and 88 in 
the proper localization of IFT particles to the initiation site for ciliogenesis.  
4. Detect interactions between core and peripheral proteins.  Yeast two-hybrid 
assays [29] will be used to determine which IFT proteins can bind with each other. This 
will allow us to unravel the mystery of how the peripheral proteins and the core proteins 
interact to form a functional complex B and will unveil the architecture of the complex B 
periphery. 
5. Isolate and characterize random insertional flagellar mutants. Random 
insertional mutants were screened for phototaxis negativity and flagellar dysfunction or 
abnormalities. Restriction enzyme site-directed amplification (RESDA) [30] was used to 
identify which genes were disrupted. Further analysis of IFT-related mutants will reveal 
a more complete picture of the structure of complex B and the functions of the individual 
IFT B proteins as they work together as a unit.                                                                                                                                                                    
By analyzing the Chlamydomonas mutants, we concluded that ift46 is able to 
form short flagella because it still forms a functional, yet unstable, complex B. Although 
ift88 maintains IFT protein stabilities and forms the complex B core, its inability to 
localize the complex B to the initiation site for ciliogenesis may account for its failure to 
assemble flagella. The bld1 mutant has decreased IFT stabilities, a disrupted complex B 
core, and a failure to localize complex B proteins to the transition fibers of the basal 
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bodies, all of these factors leading to a flagella-less phenotype. These results provided 
insight into the in vivo assembly process of complex B and revealed for the first time 
that IFT complex B first localizes to the proximal end of the centrioles and then 
translocates onto the transition fibers via an IFT88-dependent mechanism. Results from 
yeast two-hybrid assays and identification and characterization of novel IFT mutants will 
also increase our understanding of the IFT process and the assembly and structure of IFT 
complex B.  
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CHAPTER II 
DISSECTING THE SEQUENTIAL ASSEMBLY AND LOCALIZATION OF 
INTRAFLAGELLAR TRANSPORT PARTICLE COMPLEX B * 
 
Introduction 
Complex B is made up of peripheral proteins and a core (Figure 1) which can be 
further divided into at least three smaller subcomplexes:  IFT27/25, IFT88/70/52/46, and 
IFT81/74 [11-15]. IFT52 is thought to be the bridge between these three subcomplexes 
[13]. The specific purposes of and interactions between each of the IFT B proteins are 
not completely understood. Even though IFTs 46, 52, and 88 are members of the same 
subcomplex B [13,16], they may serve different functions for ciliogenesis. This is 
evident when characterizing the phenotypes of null mutants. Chlamydomonas reinhardtii 
ift88 [17] and bld1 [18] (an IFT52 null mutant) have completely flagella-less 
phenotypes, while ift46 [19] is able to produce short flagella (Figure 2). Therefore, 
IFT52 and IFT88 are required for ciliogenesis, while IFT46 is not, signifying different 
roles for these three IFT B core proteins. Here we seek to understand the functional 
differences between these three proteins in the complex B core by analyzing the 
                                                 
* Reprinted with permission from “Dissecting the Sequential Assembly and Localization of Intraflagellar 
Transport Particle Complex B in Chlamydomonas” by Richey EA, Qin H, 2012. PLoS ONE, 7(8): e43118. 
doi:10.1371/journal.pone.0043118, Copyright [2012] by Elizabeth Richey. 
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stability, localization, and status of assembly of the complex B core in ift46, bld1, and 
ift88 mutants. 
Results  
IFT46 Is Not Essential for Complex B Assembly  
 Sucrose density gradients were used to investigate the assembly status of IFT 
complex B in ift46, ift88, and bld1/ift52 mutants (Fig. 3). In wild type (Fig. 3A), all 
probed complex B core proteins cosedimented at about 15S, representing the 
preassembled complex B. Consistent with previous findings [7,9,31], IFT172, a 
peripheral B protein, peaked at about 13S, confirming that this peripheral protein can 
readily dissociate from complex B without disrupting the structure of the complex.  
IFT B proteins from ift46 mutant showed a very similar sedimentation pattern to 
wild type (Fig. 3B).  Like wild type, all the IFT B proteins peaked at about 15S. 
However, IFT52 had an additional peak at about 11S, indicating that this protein exists 
in two separate complex forms. The 11S complex likely serves as an intermediate 
transition complex, while the 15S complex is a completely or almost completely 
assembled complex B. IFT74 and IFT81, however, were only found at the 15S peak 
together with IFT52 and there were no free IFT74 and IFT81 proteins. There was a 
dramatic increase in the amount of 6S IFT27/25, indicating that a significant fraction of 
IFT27/25 freely exists. Based on these results, we concluded that IFT46 is not required 
for assembly of the IFT complex B. Since short flagella do form in ift46 mutant [27], the 
15S complex B is likely functional and capable to support flagellar assembly.  
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When co-expressed in E. coli, complex B proteins assemble into several 
subcomplexes including two tetrameric subcomplexes, IFT81/74/27/25 and 
IFT88/70/52/46, and two dimer complexes, IFT27/25 and IFT81/74 [12-14,32]. The 
ift46 mutant contained the 15S complex B, an 11S transitional complex, and a free 
IFT27/25 complex (Fig. 3B). IFT52, IFT25, and IFT27 were found in the 11S complex, 
thus the 11S complex likely is comprised of IFT88/70/52/27/25. Interestingly, IFT81 and 
IFT74 were only detected in the 15S complex, with no free IFT81/74 complex. 
Therefore, unlike IFT27/25 subcomplex, the IFT81/74 complex does not exist 
independently. This result is consistent with previous findings that the full length 
IFT81/74 expressed in E. coli is insoluble [13]. The IFT81/74 complex may not be stable 
without being bound to the complex B core proteins and thus quickly degrades in vivo. 
Taken together, these results showed that the complex B core appears to assemble in a 
sequential order: the IFT88/70/52/46/27/25 subcomplex would have to form first in 
order to allow IFT81/74 to assemble onto the core.  
In the ift46 mutant, complex B proteins still assembled into the 15S complex, 
which clearly showed that IFT46 is not required for assembly of the IFT complex B. 
However, without IFT46 the efficiency for assembly is reduced, which allows the 
accumulation of the 11S intermediate transitional complex (Fig. 3B). IFT46 is likely 
assisting in the efficient binding of the subcomplexes IFT81/74 and 
IFT88/70/52/46/27/25 to form the complex B core.   
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IFT88 Is Not Essential for Complex B Core Assembly, but is Required for Peripheral 
Proteins to Attach to the B Core 
In ift88 mutant cells, complex B proteins formed a small complex sedimenting at 
about 12S (Fig. 3C) [33], indicating the complex B core is still intact, but at least some 
peripheral proteins fail to assemble onto the core. Therefore, IFT88 is not required for 
IFT complex B core assembly, but rather bridges peripheral proteins to the core.   
IFT52 Is Essential for Complex B Core Assembly 
Previous pair-wise interaction studies have shown that IFT52 binds directly to 
the IFT81/74/27/25 complex [13], which leads to the possibility that IFT52 serves as a 
bridge to connect the two tetrameric complexes, IFT88/70/52/46 and IFT81/74/27/25, to 
form the complex B core. However, it is unclear whether association of these two 
tetramers solely depends on IFT52. Unlike the ift46 and ift88 mutants, the bld1 cells 
showed a much disrupted complex B (Fig. 3D, E). Since this mutant had extremely 
reduced amounts of IFT proteins (Fig. 4A), we were only able to detect IFT46, IFT25, 
and IFT27 on the gradients. IFT46 peaked at about 11S. This 11S complex likely 
contained IFT88, IFT70, and IFT46. Interestingly, unlike the 11S intermediate transition 
complex found in the ift46 mutant (Fig. 3B), IFT25 and IFT27 were not detected in the 
11S fractions in the bld1 mutant (Fig. 3D, E). Therefore, the 11S complex of bld1 was 
only composed of the IFT88/70/46 subcomplex, but not IFT27/25. The intermediate 
transition complexes, IFT27/25 and IFT88/70/46, stayed as two separate subcomplexes 
that failed to assemble into the complex B core in the bld1 mutant. Based on the results 
from the ift46 and bld1 mutant gradients, we concluded that IFT52, but not IFT46, is 
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essential for the binding of IFT88/70/52/46 and IFT27/25. During complex B core 
assembly, IFT88/70/52/46 and IFT27/25 must assemble into the complex 
IFT88/70/52/46/27/25 to allow the subsequent binding of IFT81/74.   
The Sedimentation Pattern of IFT27 Is Unique from Other Proteins 
Unexpectedly, IFT27 formed at least three peaks in wild type (Fig. 3A), which is 
different from what we have observed previously [14]. Prior studies show that IFT27 
forms two peaks, one with complex B, and the other in the dimer complex IFT27/25. 
The third complex that we observed sedimented at approximately 9S. The IFT B 
proteins that we probed did not cosediment at 9S, thus this 9S complex contained IFT27 
bound to other unknown proteins. The 9S complex was observed not only in wild type, 
but also in ift46 and bld1 mutant cells (Fig 3B, C and D). However, the 9S complex was 
not observed in ift88. One possible explanation to this phenomenon is that in wild type, 
bld1, and ift46 mutants, IFT27 forms a subcomplex with one or a group of the peripheral 
proteins, whereas it is unable to do so in the ift88 mutant since IFT88 may be required to 
recruit these peripheral proteins and allow binding to IFT27. Checking the sedimentation 
patterns of peripheral proteins to see if they peak with the 9S IFT27 subcomplex will 
allow us to test this idea.   
IFT25 is a highly phosphorylated protein. The higher molecular weight band 
represents the phosphorylated form since it migrates slower on the gel [14]. The 
phosphorylated and the non-phosphorylated IFT25 were readily separated on the ift88 
and bld1 gradients (Fig. 3C, D and E). Interestingly, IFT27 cosedimented with the 
phosphorylated form of IFT25 at approximately 6S, but not with the non-phosphorylated 
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form. These results hinted that the phosphorylation of IFT25 regulates the binding 
between IFT27 and IFT25.   
IFT46 and IFT52 Are Important for IFT Complex B Protein Stabilities, While IFT88 Is 
Not 
Based on western blot analysis of whole cell protein extracts (Fig. 4A), the 
mutants ift46, bld1, and ift88 all showed greatly reduced amounts of complex B proteins 
when compared to wild type cells. IFT25 was an exception and followed a similar 
pattern to IFT A rather than B proteins. This may be because IFT27/25 subcomplex is 
stable apart from the core complex and therefore if IFT B proteins are reduced, it is not 
affected as the other B proteins. Complex A proteins were not reduced but rather were 
either increased, as in ift46 and ift88, or remained constant, as in bld1. This is consistent 
with previous findings that complex B mutants often have overexpressed complex A 
proteins and under-expressed complex B proteins [17,23,27,34]. Of the three mutants, 
bld1 had the greatest reduction in complex B proteins, suggesting that IFT52 is 
extremely important for maintaining cellular levels of complex B proteins. IFT46 and 
IFT88 are also very important for maintaining cellular levels, but to a lesser extent than 
IFT52. 
A cycloheximide treatment time-course experiment was conducted to measure 
the degradation and turnover rates of IFT proteins in these mutants. IFT proteins were 
very stable in wild type cells with no noticeable degradation within 16 hours of 
treatment (Fig. 4B). The ift88 mutant cells showed a slight decrease but near wild type 
stabilities of IFT proteins (Fig. 4C). In contrast, except IFT25 and IFT27 (data not 
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shown), ift46, and bld1 cells had an extreme decrease in IFT B protein stabilities, with a 
dramatic drop in the amount of IFT B proteins within 4 hours of treatment (Fig. 4D, E). 
Thus IFT46 and IFT52 are important for preventing degradation of IFT complex B 
proteins. 
IFT Particle Proteins and the Anterograde Motor Fla10 Have Independent Stabilities 
To understand whether the defective complex B affects the expression of the 
anterograde IFT motor Fla10, the whole-cell amount of FLA10, a subunit of the Fla10 
motor, was tested in ift46, bld1, and ift88 mutants. FLA10 appeared either at the same 
level or slightly higher than that of wild type (Fig. 5A). A cycloheximide time-course 
treatment showed that FLA10 was very stable in wild type cells, and in ift46, bld1, and 
ift88 mutants (Fig. 5B). Thus, the reduced amounts of complex B proteins (Fig. 4A) or 
reduced stabilities of B proteins (Fig. 4D, E), do not affect the stability of FLA10. 
A reciprocal cycloheximide time-course treatment experiment of fla10, a null 
mutant of a FLA10 allele, was carried out to examine if the lack of FLA10 affects the 
stabilities of complex A or B proteins. Throughout the 16 hour cycloheximide treatment 
there was no reduction in IFT proteins (Fig. 5C). Taken together, these results 
demonstrated that the stability of IFT particle proteins and the anterograde motor Fla10 
are regulated through independent mechanisms.  
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Figure 4. IFT46 and IFT52 are important for IFT B protein stability, while IFT88 is not.  Western blot analysis of whole cell 
extracts of untreated strains or strains treated with cycloheximide. Coomassie-stained gels (in blue color) were used to show equal 
protein loadings. (A) Bld1, ift46, and ift88 have different levels of reduction of IFT B proteins, and an increase or no change in IFT A 
proteins; Bld1 shows the most extreme change, while ift88 shows the least extreme change compared to wild type. (B–E) Cells were 
treated with cycloheximide, a protein synthesis inhibitor, to measure degradation rates of existing proteins within 16 hours of 
treatment. (B) In wild type (cc125) IFT A and IFT B proteins remain stable throughout the time course. (C) Ift88 has near wild type 
stabilities of IFT A and IFT B proteins. (D) Ift46 has stabilities much like bld1 for IFT A and IFT B proteins. (E) Bld1 has an extreme 
decrease in IFT B protein stabilities, with the exception of IFT25, and no change in stability of IFT A proteins. 
 
 
The anterograde motor Fla10 is a heterodimer kinesin-II, containing two motor 
subunits FLA10 and FLA8, and an associated protein FLA3 [35]. Fla10ts and fla3-1b are 
two temperature sensitive (ts) mutants of the subunit FLA10 [36] and FLA3 [37], 
respectively. At the permissive temperature, the mutant  proteins FLA10 and FLA3 are 
capable of supporting the flagella assembly and maintenance, but are inactivated at the 
non-permissive temperature, leading to the loss of flagella [9,36-38]. We found that at 
the permissive temperature, when these two mutants were treated with cycloheximide, 
FLA10 greatly reduced in amount within four hours of the treatment in both mutants 
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(Fig. 5D, E), indicating that the FLA10 protein is highly unstable and has a quick 
turnover rate. Since not only the fla10ts, but also the fla3-1b mutant, had reduced 
stabilities of FLA10, it is likely that each subunit contributes to the stability of the 
heterodimer Fla10-kinesin-II complex. Reduced stability of a single Fla10-kinesin-II 
complex protein causes higher turnover rate of the entire complex. 
 
 
 
 
 
 
 
 
 
 
Figure 5. IFT protein and motor stabilities are independent from each other. Western blot analysis of whole cell extracts of 
untreated strains or strains treated with cycloheximide. Coomassie-stained gels (in blue color) were used to show equal protein 
loadings. (A) Untreated cells of ift46, ift88, and bld1 had the same or slightly higher amount of FLA10 compared to wild type cc125. 
(B) The FLA10 protein was stable throughout 16 hrs of cycloheximide treatment in the wild type cells as well as in the mutants ift46, 
ift88, and bld1. (C–E) IFT A and B proteins were stable in fla10 null (C), fla10ts (D), and fla3-1b (E) mutants throughout the 
cycloheximide treatment. 
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 IFT52 and IFT88 Are Required for Localization onto the Apical End of the Basal Body 
It is perplexing that although the complex B core is intact, the ift88 mutant is 
completely flagella-less. We reasoned that the failure to assemble flagella could be due 
to mislocalization of IFT particle proteins. In wild type cells, IFT particle proteins 
localize to transition fibers that extend from the distal portion of the basal body to the 
cell membrane [38] (Fig. 6A). The side view of the staining of IFT particle proteins and 
FLA10 is seen as a band beneath each flagellum ([9,27,38] also see Fig. 6B). Similar to 
wild type, IFT139 (an IFT A protein) colocalized with FLA10 onto the basal bodies in 
the ift88 mutant cells (Fig. 6C). Interestingly, in ift88 mutant, FLA10 not only was seen 
as two bands at the apical end of the cell, but also appeared to extend further beyond the 
transition fibers and appeared to cover the entire transition zone (Fig. 6C arrows). In 
contrast, IFT139 was only observed as two bands at the transition fibers. The same 
localization patterns were also observed in bld1 mutant (Fig. 7, arrows). These results 
indicated that the anterograde motor FLA10-kinesin-II could enter the flagellar 
compartment without attaching to IFT particles. 
 
 
18 
 
 
  
 
 
Figure 6. IFT88 is required for localization of complex B proteins to transition fibers of basal bodies. (A) A cartoon to illustrate 
the position of the transition fibers in the transition zone and the proximal end of a basal body. Immunofluorescent stains showing 
localization patterns of IFT proteins within the wild type cells (B) and the ift88 mutant cells (C). The localization of FLA10 showed 
the cellular sites of transition fibers [36]. Acetylated tubulin (Ac-Tubulin) marked the basal bodies and the flagella emanating from 
the basal bodies (in wild type). (B) Both A (IFT139) and B (IFT81 and IFT172) proteins colocalized with FLA10 at the basal bodies 
and extended into the flagella in wild type cells. (B) In ift88, IFT139, an IFT A protein, colocalized with FLA10 at the transition 
fibers. FLA10 was also detected in the very distal part of the transition zone (arrows). Two B proteins, IFT172 and IFT81, however, 
localized only to the proximal ends of basal bodies. Scale bar, 10 µm. 
    
In wild type cells, IFT complex B proteins, IFT81 and IFT172, which were seen 
as two straight bands beneath the flagella, colocalized with FLA10 (Fig. 6B). However, 
in ift88 mutant, both IFT81 and IFT172 no longer colocalized with FLA10, but were 
instead localized to the proximal ends of the basal bodies, and failed to localize onto the 
transition fibers (Fig. 6C). Thus, although the ift88 mutant contained the intact complex 
B core (Fig. 3C), the failure to dock the IFT complex B onto transition fibers, the 
initiation site for flagellar assembly, could explain why the ift88 mutant cells completely 
lack flagella [23].  
To check if the proximal end basal body localization of complex B proteins 
requires them to be in the B core complex, the bld1 mutant, which contains a disrupted 
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complex B core (Fig. 3D, E), was used in immunofluorescent staining analysis (Fig. 7). 
Similar to ift88 mutant, both IFT81 and IFT172 localized to the proximal ends of the 
basal bodies, but failed to dock onto the transition fibers (Fig. 7). Thus, it is likely that 
individual complex B proteins are able to localize to the proximal ends of basal bodies, 
but their subsequent translocation onto the transition fibers require them to be in a 
completely assembled complex B.   
 
 
 
 
 
 
Figure 7. Complex B proteins localize to the proximal end of the basal bodies in bld1. Immunofluorescent stains showing 
localization patterns of IFT proteins within the bld1 mutant. Acetylated tubulin (Ac-Tubulin) showed the cellular location of basal 
bodies. FLA10 and IFT139 correctly localized onto the transition fibers of the basal body. FLA10 was also found at the very distal 
part of the transition zone (arrows). IFT81 and IFT172, two complex B proteins, were found at the proximal end of the basal bodies, 
but not on the transition fibers. Scale bar, 10 µm. 
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 Discussion 
Assembly of IFT Complex B Is Sequential and Basal Body Localization Is a Two-step 
Process 
In this study, we report that three complex B core proteins of Chlamydomonas 
have distinct roles in complex B assembly and stability and apical peri-basal body 
localization. By analyzing the intermediate complexes formed in mutants ift46, bld1, and 
ift88 (Fig. 3), this report clearly demonstrates that IFT46, IFT52, and IFT88, despite 
being in the same subcomplex [16], do not contribute equally to the assembly of 
complex B. The ift46 mutant cells are capable of assembling a relatively intact complex 
B, which is likely responsible for the assembly of the short flagella. An intermediate 
complex, likely containing IFT88/70/52/27/25, was detected in the ift46 mutant, which 
may represent a key step in complex B core assembly. Although complex B does 
assemble in ift46 mutant, the assembled complex without IFT46 is highly prone to 
degradation (Fig. 4D). The lack of stability could be the leading factor causing low 
cellular amounts of complex B proteins in ift46 mutant, which in turn is capable of 
assembling only stumpy flagella. In contrast, the bld1 mutant does not contain an 
assembled complex B core, indicating that IFT52 plays a key role in mediating the 
assembly of complex B (Fig. 3D, E). In ift88 mutant cells the complex B core still 
assembles and remains stable (Figs. 3C and 4C). However, the complex B proteins no 
longer localize at the transition fibers, but instead are restricted to the proximal ends of 
basal bodies (Fig. 6C). The failure of anchoring complex B to the transition fibers is 
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likely due to the absence of IFT88 itself or one of the peripheral proteins that failed to 
bind to the complex B. Taken together, these results revealed that the assembly of 
complex B is through a step-wise process and the localization of complex B involves 
translocation of complex B from the proximal end to the transition fibers via an IFT88-
dependent mechanism (Fig. 8). The accumulation of IFT particles on the transition 
fibers of basal bodies, where flagella assembly initiates, is obviously advantageous to 
flagellar assembly. This study provides some clues as to how IFT complex B localizes to 
the basal body. It appears that individual IFT complex B proteins are first transported to 
the centrioles (Figs. 6 and 7), where they assemble into a complex, and then translocate 
onto transition fibers.  
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proteins should provide a complete picture on the architecture and the assembly of 
complex B.   
Although IFT88 is a subunit of complex B core, it is not needed for complex B 
core assembly. Instead, its function is most likely to bind peripheral proteins to the core. 
Compared to the interactions identified within the complex B core subunits, the 
interaction between IFT57 and IFT20 is the only one that has been confirmed among the 
peripheral proteins to date [ ]. Interestingly, in ift88 mutant, the cellular level of IFT57 
is greatly reduced compared to other complex B proteins [ ]. It is possible that in the 
absence of IFT88 and IFT57, the rest of the peripheral proteins are no longer able to 
attach to the complex B core. Future work on the identification of which peripheral 
protein that interacts with IFT88 and the additional interactions among peripheral 
39
23
IFT88 Is Critical for Mediating the Attachment of Peripheral Proteins to the Complex B 
Core 
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Figure 8. Sequential assembly and basal body localization of complex B. This model shows that during complex B assembly, 
complex B core assembles and then the peripheral proteins assemble onto complex B core to form an integrated complex B. First, 
the subcomplexes IFT88/70/52/46 and IFT27/25 binds to form IFT88/70/52/46/27/25, and the binding is dependent on IFT52. The 
absence of IFT52, as seen in bld1 mutant, prevents the formation of IFT88/70/52/46/27/25, causing the accumulation of the 
intermediate transition complexes IFT88/70/46 and IFT27/25. Second, IFT74 and IFT81 assemble onto IFT88/70/52/46/27/25 to 
form the complex IFT88/70/52/46/27/25/81/74. This step is assisted by IFT46. The absence of IFT46, as seen in ift46 mutant, either 
generates unstable IFT88/70/52/27/25/81/74, which is prone to degradation or dissociates the complex into IFT88/70/52/27/25 and 
IFT81/74. IFT81/74 is insoluble and cannot exist on its own [13]. Thus, although the interaction between IFT74 and IFT81 is 
strong [12], [13], the complex 81/74 only stably forms while it assembles onto the complex B core. IFT22 is a complex B core 
protein (data not shown) but currently it is unknown how it assembles into the complex B core. Lastly, the peripheral proteins 
assemble onto the complex B core to form an intact complex B. IFT88 is not required for complex B core formation, but is essential 
for mediating the binding of peripheral proteins to the B core. All the assembly steps involved in forming complex B core may 
occur at the proximal end of the basal bodies. The translocation of complex B from the proximal end of the basal body to the 
transition fibers is dependent on the presence of IFT88 and proper association of peripheral proteins. 
 
IFT52 
IFT52 assisted by 
IFT46 
IFT88 
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IFT88 and/or Peripheral Proteins Are Essential for Anchoring Complex B on the 
Transition Fibers   
Our results indicate that IFT88 itself, or one of the complex B peripheral proteins 
that failed to attach to the complex B is responsible for the translocation of complex B 
from the proximal end of basal bodies onto the transition fibers. This idea can be tested 
by examining the assembly status and the localization pattern of complex B proteins in 
mutants of peripheral proteins. However, the set of complex B protein mutants is far 
from complete, with only a handful of complex B mutants currently available. The IFT 
complex B proteins are correctly localized to transition fibers in temperature sensitive 
mutant fla11/ift172ts (data not shown). Thus, it is unlikely that IFT172 is responsible for 
complex B transition fiber localization, although this result needs to be confirmed once a 
null mutant of ift172 is available. Recently, an ift80 mutant (likely a null mutant) was 
identified; like bld1 and ift88 mutants, this mutant is completely flagella-less with no 
axonemal microtubules assembled [40]. Further studies on the assembly status and the 
localization pattern of complex B proteins of the ift80 mutant should provide answers to 
the function of IFT80 in complex B assembly and localization. 
The Anterograde Motor Fla10-kinesin-II Must Be Recycled Back to the Cell Body After 
Each Trip to the Flagellar Tip     
IFT particles undergo constant bi-directional transport along the entire length of 
flagella to support flagellar assembly and maintenance. This report shows that both IFT 
particle proteins and the anterograde motor Fla10-kinesin-II have very low turnover rate 
(Figs. 4 and 5). By analyzing the motility of GFP tagged proteins, previous studies have 
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observed an interesting discrepancy of the movement between the IFT particle proteins 
and the Fla10-kinesin-II. IFT particle proteins display both the anterograde and 
retrograde transport. In contrast, Fla10-kinesin-II only shows the anterograde transport. 
No retrograde transport can be observed for Fla10-kinesin-II [41,42], leading to the 
possibility that Fla10-kinesin-II is discarded at the flagellar tip after completing one 
anterograde transport and never recycled back for reuse. However, here we show that 
Fla10-kinesin-II is very stable (Fig. 5). No protein amount change of FLA10 can be 
detected after 16 hours of treatment with cycloheximide. Thus, normally there must be 
little, if any, new Fla10-kinesin-II synthesized in the cell body. The protein synthesis for 
Fla10-kinesin-II can be up-regulated when the protein turnover rate is increased, as seen 
in both fla10ts and fla3-1b mutants. Such upregulation is likely required to replenish the 
depleted Fla10-kinesin-II protein due to increased degradation rate. Because the turnover 
rate of Fla10-kinesin-II is extremely low, it has to be reused to power numerous rounds 
of IFT movement. Therefore, Fla10-kinesin-II must be efficiently recycled back to the 
cell body after each trip to the flagellar tip.  
Materials and Methods 
Strains and Culture Conditions 
Strains used as controls included Chlamydomonas reinhardtii wild type strain 
cc125 and cell wall deficient, but otherwise wild type strain cw92 (CC-503). The cw92 
strain was used for the sucrose density gradients, as the cell wall deficiency made it 
easier to lyse the cells for protein extraction. These control strains along with mutant 
strains, ift88 (CC-3943) [23], ift46 [27], bld1 (CC-477) [26], fla10 null (CC-4180), and 
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temperature-sensitive mutants fla10ts (fla10-1 allele, CC-1919) and fla3-1 (CC-4283) 
were obtained from the Chlamydomonas Center (http://www.chlamy.org). The strains 
were cultured on Tris-acetate-phosphate (TAP) solid plates or TAP liquid media with 
constant aeration in a Conviron programmed at 22C in continuous light.  
Whole Cell Protein Extracts and SDS Page Electrophoresis 
20 mL TAP liquid media was inoculated with a loop of cells from a fresh (within 
a week old) TAP solid plate culture.  Liquid cultures were grown for approximately 3 
days (until medium to dark green) under the above conditions. The cultures were 
normalized based on the lightest colored culture by adding TAP liquid media to the 
others until all cultures were about the same color. 1 mL of culture was spun down at 
14000 RPM for 5 minutes and the supernatant was removed. The cell pellet was then 
resuspended in 50 µL 1X PBS. 50 µL 2X laemmli buffer was then added and the 
cultures were vortexed for 30 seconds. The samples were then boiled for 3 minutes, and 
spun down for 10 minutes at 14000 RPM. The supernatant was collected and stored at    
-20ºC for short- term or -80ºC for long-term storage. Samples were used for direct 
electrophoresis using SDS Page gels. 5 µL of sample was added to each well, then 
protein amounts were adjusted based on total lane intensity detected on gels stained with 
Coomassie Blue using ImageLabTM Software (BioRad). 
Cycloheximide Treatment 
Cells were cultured under the conditions described above. Protein was extracted 
using above protocol prior to treatment to be used as control samples. The remaining 
culture was treated with 10 µg/ml cycloheximide and again placed in the conviron under 
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the same culture conditions as pre-treatment. Protein was then extracted at multiple time 
points using the same methods used when extracting control samples.  
Western Blotting 
Protein was separated on a 10% SDS Page gel, then electro-transferred to a 
polyvinylidene difluoride membrane. Proper transfer was tested using ponceau staining. 
Membranes were then blocked in 5% nonfat dry milk in TBST (10 mM Tris, pH 7.5, 166 
mM NaCl, plus 0.05%Tween-20) with .02% sodium azide. Membranes were then 
incubated in primary antibody in blocking solution for at least 1 hour (up to one day for 
weaker antibodies). They were then washed 4 times for 10 minutes each time in TBST. 
Membranes were then incubated in secondary antibody in 5% nonfat dry milk in TBST 
for at least one hour, followed by an additional 4 washes using TBST. 
Chemiluminescence with X-ray film was used to detect antibody bands. 
Antibodies 
Antibodies used in this study included antibodies against α-tubulin (clone B-5-1-
2, ascites fluid; Sigma); IC69 (clone 1869A; Sigma); acetylated tubulin (clone 6-11B-1, 
ascites fluid; sigma); and IFT polypeptide antibodies included antibodies to 
Chlamydomonas reinhardtii IFT172, IFT81, IFT139 [9], IFT122 [11], IFT74 [43], 
IFT46 [27], IFT25 [14], IFT27 [34], and FLA10 [9]. 
Sucrose Density Gradient 
500 mL of cells were grown under conditions described above. Cells were then 
pelleted and resuspended in autolysin and shaken under light for 1 hour or until cells 
separated and were able to be lysed by 1% Triton. Cells were again pelleted and stored at 
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-80ºC. After thawing on ice, cells were resuspended in 10X HMDEK with DTT, 
followed by serial centrifugation of the supernatant at 4º C until supernatant was a clear 
yellow/green. High and low density sucrose solutions that contained 1X HMDEK were 
prepared in 12 mL centrifuge tubes and were made into gradients. The supernatant was 
placed on top of the sucrose gradients, then centrifuged at 37000 RPM at 5ºC for 18 
hours. A No Drop Counter apparatus was used to collect 500-550 µL fractions. Enough 
10X Laemmli buffer was added to each tube to make the sample 1X laemmli buffer. 
Samples were stored at -20ºC (or -80ºC for long-term storage). 
Approximate S-values were derived using the sedimentation behavior of the 
following proteins with established S-values: the prominent ~55 kDa large subunit of 
RuBisCo sedimenting at ~19S, FLA10 with known sedimentation at about 10S [9], and 
cytoplasmic radial spoke complex at 12S [43].  
Immunofluorescent Staining 
Cells were fixed in methanol and blocked with blocking buffer (5% BSA, 1% 
Cold Water Fish Gelatin, 10% goat serum in 1X PBS). Cells were then incubated in 
primary for 4 hours at room temperature or overnight at 4ºC followed by washing in 
0.5X PBS. Cells were incubated in secondary antibody for 1 hour at room temperature. 
SlowFade Antifade Reagent (Invitrogen) was used to prevent loss of signal. Cells were 
viewed under an Olympus IX-70 inverted fluorescence microscope at 100X 
magnification. An Image Point CCD Camera (Photometrics) was used to capture the 
image through PCI Software. 
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CHAPTER III 
IDENTIFYING INTERACTIONS BETWEEN CORE 
AND PERIPHERAL PROTEINS 
 
Introduction 
The aforementioned results give us a better understanding of the interactions 
among core proteins during assembly and localization. However, little is revealed about 
the interactions between core and peripheral proteins. Discovering how peripheral 
proteins assemble onto the core could lead to a better understanding of the functions of 
these proteins for ciliogenesis. The differing phenotypes of ift46, bld1, and ift88 mutants 
can now be explained. Ift46 is able to produce short flagella because it still assembles a 
nearly complete but unstable functional complex B. Bld1 has a highly disrupted complex 
B core, which causes complex B to be dysfunctional, leading to a flagella-less 
phenotype. Although ift88 still forms a somewhat complete complex B, it seems to still 
be missing some components necessary to localize complex B to the transition zone, 
making the mutant unable to perform ciliogenesis. It is unlikely that IFT88 is responsible 
on its own for proper localization. Conversely, we predict that IFT88 interacts with at 
least one peripheral protein that is important for the localization of complex B to the 
initiation site for ciliogenesis. Here we use yeast two-hybrid assays [29] to determine 
protein interactions between IFT88 and peripheral proteins. So far, the only interaction 
known between the peripheral proteins is IFT57 and IFT20 [39]. Therefore we will also 
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identify the interactions between peripheral proteins themselves to further investigate 
peripheral assembly and architecture.  
Results and Discussion 
 This project is currently in progress, so there is little to report at this time. Yeast 
two-hybrid assays [29] will determine the interactions between IFT88 with peripheral 
proteins IFT20, IFT57, IFT80, and IFT54. In addition, binding ability between IFT20 
and IFT80, IFT20 and IFT54, IFT57 and IFT80, IFT57 and IFT54, and IFT80 and IFT54 
will be tested to determine the peripheral architecture of complex B. 
 Primers were designed for each gene so that when the fragments were amplified, 
they would contain restriction enzyme sites at both ends. These fragments were then 
ligated into TA cloning vectors and transformed into E. coli. The plasmids were 
extracted and purified from the transformants. Next, they were digested with the 
respective restriction enzymes and tested by gel electrophoresis for the presence of the 
gene and for its ability to digest completely. When confirmed, the digested fragments 
were then ligated into plasmids that allow the expression of fused proteins containing 
either a GAL4 activation domain or binding domain. This is the current stage of the 
project. When the ligations are confirmed, they will be transformed into yeast. The 
reporter gene, LacZ, will only be transcribed if both the activation and the binding 
domains are able to bind onto the DNA to recruit polymerase. If the bait protein (fused 
to GAL4 binding domain) directly interacts and binds to the prey protein (fused to 
GAL4 activation domain), transcription of LacZ will be activated in the presence of 
IPTG to allow the production of β-galactosidase. This will break down supplemented X-
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Gal to produce colonies with a blue color, allowing selection of protein combinations 
with positive binding ability [29].  This system will allow us to determine which of these 
peripheral proteins bind to each other and which can bind to the IFT88 core protein. This 
knowledge is important to add to the current understanding of the architecture of IFT 
complex B because it will lead to a better grasp on how complex B works as a whole to 
allow the proper performance of IFT and ciliogenesis. The more we understand about 
this process, the more likely our research will lead to practical applications in preventing 
ciliopathies.  
Materials and Methods 
Strains and Culture Conditions 
TOP10 (Invitrogen™) chemically competent E. coli strains were used for TA 
cloning of the PCR products.  JM109 cells were used for transformation of the pGADT7 
and pGBKT7 ligations into E. coli to confirm the insertion and to isolate and purify the 
plasmids for transformation into yeast. E. coli strains were grown in solid or liquid LB 
media with either Ampicillin or Kanamycin for selection, depending on the plasmid 
antibiotic marker. IPTG and XGal were also supplemented on the plates when necessary 
for blue/white colony screening. For transformations, plates were incubated at 37ºC 
overnight. Selected colonies were grown at 37ºC in liquid LB with antibiotic overnight 
to be used for plasmid purification. 
The yeast strain used was AH109 (Clontech). This strain helps prevent false 
positives since it contains ADE2, HIS3, lacZ and MEL1, which are reporter genes that 
have promoters which respond to GAL4. Transformants were grown on SD/-Ade/-His/-
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Leu/-Trp/X-gal to ensure that the only blue colonies were true positives with the bait and 
prey fused proteins bound to each other, allowing the transcription of LacZ and the 
production of β-galactosidase. Cultures were grown in accordance with the 
Matchmaker™ GAL4 Two-Hybrid System 3& Libraries User Manual (Clontech). 
Plasmids 
TOPO TA vectors (Invitrogen™) were used for cloning gene products to allow 
for more efficient digestion in order to generate effective ligations into vectors used for 
yeast transformation. These vectors were pGADT7, which produces a protein product 
fused to GAL4 DNA activation domain (prey), and pGBKT7, which produces a protein 
product fused to GAL4 DNA binding domain (bait). Both of these vectors contain a T7 
promoter which allows for the expression of the fused proteins. They also include two 
origins, pUC for replication in E. coli and 2 µ for replication in yeast. pGADT7 contains  
an Ampr  marker and a LEU2 nutritional marker for selection in E. coli and yeast, 
respectively. pGBKT7 contains  an Kanr  marker and a TRP1 nutritional marker for 
selection in E. coli and yeast, respectively. 
Primer Design 
Primers were designed so that the entire gene from each of the selected proteins 
could be amplified from a cDNA clone template. In addition, restriction enzyme 
sequences were added to the 5’ ends of the primers to allow for future ligation into the 
plasmids that will be transformed into yeast (Table 1). Enzyme sequences were selected 
so that when ligated into the yeast plasmids, they would not change the reading frame. 
Enzyme sequences that were present within any of the genes were generally avoided so 
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that we did not have the risk of inserting an incomplete gene into the plasmid. For all 
genes except IFT80, the selected enzymes were NdeI for the forward primers and EcoRI 
for the reverse primers. IFT80 was an exception since it contained an EcoRI site within 
the gene. In this case, BamHI was used for the reverse primer instead of EcoRI. An extra 
GC was added to the 5’ end of each primer to prevent the degradation of the enzyme 
sites at the ends of the PCR products.  
 
 
Table 1. Primers Used for Yeast Two-Hybrid Assay 
Gene Primer Sequence Restriction Site 
IFT88 (Forward) GCCATATGAGCTACGGGGGCACGGAG NdeI 
IFT88 (Reverse) GCGAATTCTTACATGGGCAGCAGGTCGTCC EcoRI 
IFT80 (Forward) GCCATATGCGTCTCAAGGTCAAGCAGTCCAG NdeI 
IFT80(Reverse) GCGGATCC TTACACGTAGCGCTTGGCG BamHI 
IFT57 (Forward) GCCATATGCCGCAGGAAATGCTGGCCG NdeI 
IFT57 (Reverse) GCGAATTCCTAGTCCTCCTCCTCGTCACTG EcoRI 
IFT54 (Forward) GCCATATGTGCGATAACTGGCAGGCAACCATTG NdeI 
IFT54 (Reverse) GCGAATTCTTACCGCCCAGCGGTTGCC EcoRI 
IFT20 (Forward) GCCATATGGACGCGGTAGATAGAGGAGTCTACT NdeI 
IFT20 (Reverse) GCGAATTCTTACACGTATGCCGCCCCGC EcoRI 
 
 
PCR 
 PCR was used with the above primers to amplify genes from clones, cDNA, or a 
cDNA library. These amplified fragments were inserted in TA cloning vectors for 
efficient digestion. For PCR reaction and program information see Secondary RESDA 
methods in the next chapter. 
 Cloning and Plasmid Extraction 
PCR products were cloned into TOPO TA vectors and transformed into 
chemically competent TOP10 E. coli strains using the TOPO® TA Cloning® Kit for 
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subcloning with TOP10 E. coli (Invitrogen™). pGADT7 and pGBKT7 ligations 
containing the desired gene inserts were transformed into JM109 Chemically competent 
cells using the transformation protocol found in the pGEM®-T and pGEM®-T Easy 
Vector Systems Quick Protocol (Promega). Plasmids were extracted using the 
GeneJET™ Plasmid Miniprep Kit (Fermentas). Protocols found in the Matchmaker™ 
GAL4 Two-Hybrid System 3 & Libraries User Manual (Clontech) were used for 
transformations intoAH109 yeast cells.   
Digestions and Ligations 
 TA plasmids were double digested with the inserts’ respective restriction 
enzymes (Fermentas). Gel electrophoresis was used for double digests to separate the 
fragments from the plasmids. This allowed confirmation that the TA cloning was  
successful. Fragments were purified with the GeneJET™ Gel Extraction Kit 
(Fermentas). These purified fragments were ligated into pGADT7 and pGBKT7using T4 
DNA Ligase (Invitrogen).   
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 CHAPTER IV 
IDENTIFICATION AND CHARACTERIZATION OF RANDOM INSERTIONAL 
FLAGELLAR MUTANTS 
 
Introduction 
Little is known about the functions of the peripheral B proteins, how they are 
assembled onto complex B, and what their functions are in localizing, regulating, and 
stabilizing the complex. So far, there are only a couple mutants available for peripheral 
B proteins, among these are fla11 [31] (temperature sensitive mutant for IFT172) and 
ift80 [40] (likely a null mutant). Though these mutants will be useful for gaining insights 
into the functions of these proteins, it is important to screen for new mutants of the other 
peripheral proteins in order to develop a complete picture of the inner workings of 
complex B for ciliogenesis. 
To attempt to identify a novel IFT complex B peripheral mutant in 
Chlamydomonas reinhardtii, random insertional mutagenesis was performed. Mutants 
were then screened for flagellar defects and flanking sequences were identified using 
restriction enzyme site-directed amplification (RESDA) PCR [30]. A few interesting 
mutants have been identified, but none thus far that are of interest to this project. 
RESDA screening will continue in hopes of identifying a peripheral protein novel 
mutant, which would be a great tool to determine the roles that the periphery of complex 
B plays on the stability, assembly, and localization of IFT complex B. 
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Results and Discussion 
Random Insertional Mutagenesis 
 Novel Chlamydomonas IFT and flagella-related mutants were created by 
randomly inserting a linearized plasmid into the genome of wild type cells. The plasmid 
used contains a hygromycin resistant gene allowing for selection in media supplemented 
with the antibiotic. Restriction enzyme ScaI was used to linearize the plasmid during the 
production of the first few sets of mutants. The plasmid only has one ScaI site available 
for digestion, so the inserted fragment was the entire 4.4 kb plasmid. It proved to be very 
difficult to work with these mutants due to possible religation or failure to digest the 
plasmid properly, multiple inserts throughout the genome, or a chain of inserts within a 
gene (Fig. 9). It is unclear whether our difficulty was due to the size or nature of  
 
 
 
 
 
 
 
 
 
 
Figure 9. Multiple insertions or improper digestion of plasmids are common among random insertional mutants made with 
pHyg3 cut with ScaI. Eleven mutants and the digested fragment of pHyg3 were tested using primers Up5 and Dwn1, which are 
found on either side of the ScaI restriction site. All templates produced fragments at the predicted size of ~630 bp. These results show 
that the plasmid either failed to digest at ScaI, somehow religated itself, or there are multiple consecutive inserts in each of the tested 
mutansts. 
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the insert, but we changed the procedure for the new sets of mutants to see if reducing 
the size of the inserted fragment would make the screening and identification process 
more efficient. For the newer mutants, the enzyme HindIII, having two restriction sites, 
was used to cut out the fragment containing just the promoter, hygromycin resistant 
gene, and untranslated region of pHyg3 so that it still could express the marker gene. 
Mutants made with these much smaller 1.7 kb fragments showed to be more consistent, 
with fewer multiple inserts or strange ligation and digestion behavior, making 
identification of the disrupted gene much more feasible. However, many of these strains 
are most likely not null mutants for any particular gene and would be difficult to 
characterize since they had insertions in extragenic regions. To attempt to solve this 
problem, future mutants will be made using a PCR product that contains the hygromycin 
gene but lacks the promoter. This means that the only time a transformant will be able to 
survive on hygromycin would be when the fragment was successfully inserted inside a 
gene, using the genomic promoter to express the selective marker gene. This technique 
should greatly increase the chances of getting a null mutant from the screening process. 
Screening for IFT Mutants  
For this project, our main interest is in peripheral IFT B genes that do not yet 
have null mutants available to the research community, such as IFT57, IFT20, or IFT54. 
To screen for potential flagellar mutants, strains were first tested for a failure to phototax 
(Fig. 10). Cells that were unable to swim toward light most likely had a sensory 
dysfunction and/or deformed and malfunctioning flagella. All strains that could perform 
phototaxis were discarded and all phototaxis negative strains were then examined under  
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the microscope. Each strain was characterized and categorized based on its visible 
flagellar phenotype. Because some mutants had multiple or inconsistent phenotypes, it is 
advisable to grow several single colonies from each mutant to eliminate contamination 
and separate mixed strains for accurate analysis before attempting to identify the 
mutated gene. A variety of phenotypes were observed including mutants with flagella 
that were short, long, have unequal length, abnormal number, motility deficiency, or 
atypical accumulation of proteins. For this study, strains with short or no flagella (bald) 
were of the most importance, since these are typical phenotypes seen in known IFT B 
mutants. However, the proteins most interested in are not core proteins, so they may 
have less of an effect on ciliogenesis but may be involved in a more discreet function. 
Therefore, mutants with phenotypes besides bald or short flagella were not ruled out.  
In addition to the phototaxis assay and microscopic analysis, western blotting 
was also useful for narrowing down the mutants to ones likely to be null for complex B 
proteins. Typically a strain that is deficient in a complex B protein will show the pattern 
of a reduction in other B proteins and an increase or lack of change in IFT A proteins, 
Figure 10. Phototaxis assay. Cultures in liquid TAP media were placed in test tubes and incubated in a phototaxis box in which 
only one slit of light could shine through. Phototaxis strains showed a distinct line of green where the light shone through, while 
phototaxis negative mutants had a homogenously green culture solution or had cells sink to the bottom of the tubes. 
  +        - 
 
 
39 
 
 
while maintaining a normal expression of IFT motor proteins. Conversely, an IFT A 
mutant typically has a reduction in other IFT A proteins, while B protein expression 
remains the same or is increased. Twenty-two bald mutants were tested for patterns 
characteristic of an IFT B protein mutant by probing with one A, one B, and one motor 
protein antibodies. Based on their expression patterns, three mutants were identified as 
potential IFT B mutants while two showed similar patterns to complex A mutants. In 
addition, one mutant showed normal expression of both IFT A and B proteins, but had a 
drop in FLA10 motor protein production, making this a possible IFT motor mutant (Fig. 
11).  
 
To test the mutants for mutations in specific IFT genes, primers were designed to 
amplify the genes of interest using PCR. If the insert disrupted the gene, the primers 
would not yield a result since there would be either a shift in the genomic sequence or a 
deletion, preventing efficient amplification of the fragment. Many mutants were 
B 
 
A 
 
Motor 
 
Figure 11. Western blot analysis of whole cell extracts revealed potential IFT mutansts. 6P1, 6P10, and 2P40 are possible 
B mutants, having a reduction of IFT B protein expression, while maintaining or increasing the expression of IFT A proteins. 
6P11 and 6P7 are potential A mutants, having a reduction in expression of IFT A proteins, while maintaining expression of IFT 
B proteins. 6P9 may be a motor protein, since it has a reduction in a motor protein, but not in IFT A or B protein expressions. 
Coomassie staining shows the relative loaded protein amounts. 
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screened using this method, but all mutants tested produced a band for each set of 
primers, thus yielding no confirmed mutations in the desired genes. This method of 
screening, although it can be specific to a particular gene and performed quickly in high 
quantities, proved to be an inefficient way to identify mutated genes in the case of our 
mutants. Therefore, restriction enzyme site-directed amplification (RESDA) PCR [30] 
was applied as a sequencing approach to the identification of the mutations. 
RESDA PCR 
RESDA PCR is a way in which one can amplify flanking sequences of an 
inserted fragment so that they can be sequenced for identification of a disrupted gene. 
Two PCR reactions were performed for this method. Degenerate primers, which 
included a restriction enzyme sequence and a known sequence (Q0), were paired with 
primers homologous to known insert sequence near the ends of the fragments for the  
primary RESDA reaction (Fig.12). Degenerate primers, on their own, are mostly 
nonspecific and can bind to almost anything. The restriction enzyme sequence within  
 
Up4   Up3      Spec U2 
Dwn1 Dwn2     Spec D 
SacI      Q0 
SacI      Q0 
Known seq. of ends of insert 
Degenerate region 
Unknown genomic seq 
Primers 
Figure 12. RESDA PCR. Degenerate primers contain a restriction enzyme sequence which allows binding at restriction sites 
throughout the genome. When one binds close enough to the insert, a product containing the flanking sequence of the insert can 
be made. The primary RESDA PCR is performed by amplifying the insert flanking sequence using Up4 and degenerate primers 
for one end of the insert, and Dwn1 and degenerate primers for the other end. The primary product is then used as the template 
for the secondary reaction which amplifies the fragment with Up3 and Q0 primers for one end, and Dwn2 and Q0 for the other. 
SpecU2 and SpecD are used to test the specificity of the Up and Dwn primers, respectively.  
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these primers allowed them to selectively bind to any site in the genome that contained 
its respective restriction enzyme sequence. When the primers were bound to a region  
that was near the insert, a product was formed with the primers on the ends of the insert. 
A secondary reaction was used to increase specificity of the product. For this reaction, 
the product from the primary reaction was reamplified using a primer that matched the 
known sequence (Q0) on the degenerate primer and one closer to the end of the inserted 
fragment than the previously used insert primer (Fig. 12). The reason we did not use the 
same insert primer was to increase the efficiency of the PCR since amplifying the very 
end of a sequence often does not yield clean results. The product of the secondary PCR 
reaction was then run on a gel and bands that were large enough to include enough 
genomic sequence were extracted for sequencing [30].  
The success of this procedure relied not only on the methods used for 
mutagenesis but also on how the PCR was performed. Standard Taq polymerase and 
buffer were used in the first RESDA attempt, yielding smeared bands and bands that 
were too small to include enough genomic DNA for sequencing. To resolve this problem 
we started using GoTaq® DNA Polymerase and buffer (Promega), which are more 
robust and reliable reagents for amplification of products that are problematic, such as 
ones amplified with degenerate primers. Although these reagents greatly increased the 
success rate, the high efficiency of amplification of even the smallest amount of DNA 
template made the PCR much more prone to the effects of contamination. Much time  
was spent on troubleshooting contamination issues, and it is advised to take all necessary 
precautions to prevent these issues during handling of reagents and DNA. Contamination 
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issues aside, RESDA PCR has shown promise in identifying flagellar mutants from our 
screen in an efficient and effective way.  
Identification of IFT80, PF16, and CEP290 Mutants 
 Thus far, five flagella-related mutants have been identified using the RESDA 
PCR method. Among these are IFT80 (Fig. 13 A), PF16, and CEP290 mutants. Since 
null mutants for these genes are already available to the scientific community, these 
mutants did not strike our immediate interest and we are continuing to screen for more 
interesting novel mutants. However, the three strains may still prove useful in the future 
for projects relating to these proteins. 
 IFT80 is an IFT B peripheral protein that has been linked to serious ciliopathies 
such as Jeune asphyxiating thoracic dystrophy[44] and short-rib polydactyly syndromes 
[45]. It also has been shown to play roles in important pathways such as the hedgehog 
signaling pathway [45]. Here, the mutant that had a disruption in IFT80 had short  
flagella that were immotile. This is unlike the bald phenotype of the previously  
discovered Chlamydomonas ift80 [40] mutant, meaning it could be that our mutant is not 
null for IFT80 or that it is not an IFT80 mutant at all. Since our strain is able to produce 
flagella, the cells either have some functioning IFT80 proteins available for IFT, or the 
phenotype of the previously identified ift80 mutant [40] was not characterized properly. 
The region of our sequencing result that matched nearly perfectly with IFT80 was about 
200 bp, so there is little chance it was a false match. PCR was used to attempt to confirm 
the mutation (Fig. 13B, C). First a primer from the matched region of IFT80 was used 
with a primer from the end of the insert so that if the sequencing results were correct, the 
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DNA from the mutant would produce a product. However, the results were inconclusive 
since wild type and mutant DNA both produced a nonspecific band. A primer from the 
other end of the insert along with a primer within the presumed flanking IFT80 sequence 
300 bp 
600 bp 
 
A 
B RESDA product match Primers: IFT80F  IFT80D  IFT80U 
 TCGTATGCCCTCTGCGCATGCAGGTCAGCACTCTGGACGCATAC
TTCACGGATATGCACTGGTACCCCGTGAGCTCGAAGAAGACGC
AAGCAGGCGGGACGGACGTATTCGCGGTGGCGTGCACAGACG
GTGCGTCCGGTTGGCTGCACTCGCCGTGTGGTACCCTGGCGGG
CCGCTCAACTATGGCGACCCTCCTCCCGTTCCAGTGCTAACACG
CATCGGCGTCTCCCCTCGCAGGCTCTGTAAAAATCCTCAGCCGC
ACGGGCCGCGTGGAGAAGTCCATTGAGGGGCACAAGGGCGCG
TGCATCTCGCTGCGCTGGAGCTATGACGGTGCGTCTGGGGGCA
GGGGCACACGCACACACACCTCTCCAGCCCACACATACGGTAC
TCCACCCAGCACACCTCCACCGTACCCAGCACCCCCCACCCAAC
ACTCGCCCACCGCCCACCTCGACCCGCAGGGACGGCACTGGCG
ACGGCGGGCGAGGACGGGTCGGTAAAGATCTGGTCGCGCAAC
G------<-Dwn3-----------------pHyg3--------------------Up5->------
GCATGCTGCGCTCCACGCTAGCGCAGGCGGACAGCCCCGTGTA
CTCGATTGTGTGGGCCTACGACTGCGACCAGCTGTGCTACTGC
ACCGGCTCCAACGTGGTCATCAAGTCGCTGTCCTCCAACGCCAA
GCAGAACGCGTGGAAGGCGCACGACGGCGTGGTGCTCAAGGT
GGACTGGAGCCCCATCAACCACCTCATCATCACAGGCGGCGAG
GACTGCAAGTACAAGGTGTGTGCGTGTGTGTGCGTGTGTGTGC
GTGTGTGTGCGTGTGTGTGCGTGTGTGTGCGTGTGTGTGTGTG
TATGTGCGTGTGTGTGCGTGTGTGTGTGTGTGTGTGCGTGTGT
GTGTGTGTGTGTGTGTGTGTGCGTGCGCGGCACACCGAGGGA
GGGAGGGCAGGCAGGCAGGGAGAATGCGGGAGTGGTGTCGC
ACAGCGAGAAGGGCTGGATGGCGAGGGGCGAATCTTGGTTGA
GCCGCGGCGGCGGCGGCGGCTGTCTCTGACACGTGCGAATGC
ACGCCGCAGGTGTGGGACAGCTTTGGGCGGCTGCTGTT 
C 
D 
Figure 13. A possible IFT80 mutant is yet to be confirmed. (A) Sequencing results of mutant 5P3 using both Up5 and Q0 
primers showed that the flanking sequence matched a ~200 bp portion IFT80. Results also showed that the plasmid was either 
not cut at ScaI as expected or that there were multiple consecutive inserts. Two inserts are shown with hypothesized cut sites. 
The first is based on when our fragment’s sequence stopped matching pHyg3 and the second is based on when it started 
matching IFT80. (B) IFT80 sequence with predicted location of the pHyg3 insert. Primers used for confirmation are highlighted. 
(C) PCR and gel electrophoresis showed that wild type and 5P3 did not produce a band with IFT80 and Dwn3 primers. 
Nonspecific bands were amplified with Up5 and IFT80U primers. Amplification with IFT80U and IFT80D showed that wild 
type and 5P3, along with another mutant 2P40, all have intact IFT80 sequence in the region that was expected to be disrupted. 
(D) Western blot analysis showed a possible band for IFT80 in 5P3, but the antibody is too dirty and nonspecific to trust.    
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produced no bands in either wildtype or the mutant. This is also inconclusive, but it 
could mean that the insertion caused a deletion in IFT80 so that the flanking sequence is 
not as predicted. Two IFT80 primers that were on either side of the expected insert 
location were also used. Results showed that the mutant still had an intact IFT80 
fragment where we previously thought it was disrupted. It is possible that there was 
contamination of the strain with wild type or one of the other mutants to produce this 
band. In addition, when probed with IFT80 antibodies, western blots showed that IFT80 
was present in the mutant (Fig. 13 D). However, this result cannot be trusted since the 
antibody is dirty and may be nonspecific. A new antibody should be made to confirm 
this result. Apart from the initial sequencing analysis, all the results cause doubt in this 
mutant and more work needs to be done to determine if it is in fact an IFT80 mutant. 
Since this gene already has a mutant available, it was set aside for future analysis.   
 A PF16 mutant was also produced from the RESDA PCR screen. PF16 is a 
central pair protein that is involved in flagellar motility most likely by maintaining the 
stability of the C1 central microtubule [46]. Both our mutant and Chlamydomonas pf16 
[46] share a common paralyzed phenotype, which is consistent with a central pair 
deficient axoneme. To further support that this is a PF16 mutant, PCR with two PF16 
primers flanking the location of the insert (Fig. 14A) were used to test for disruption in 
the gene. As expected, wild type produced a very strong band at the predicted size of 
~300bp, while the mutant only produced an indistinguishable smear. In addition, a PF16 
primer and a primer near the end of the insert (Fig. 14A) were able to amplify a ~1200 
bp band in the mutant, but not in wild type (Fig. 14B). These PCR results and the  
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phenotype consistent with a central pair mutation make us more confident that we have a 
PF16 mutant. Further PCR and sequencing, back-crossing, and rescue of the phenotype 
will confirm the mutation. Again, since there is already a PF16 mutant available, this 
mutant was not pursued. 
 Lastly, a mutant was identified to have a disruption in CEP290, a gene that codes 
for a microtubule protein in the transition zone that is required to link the flagellar 
membrane to the microtubules and to regulate flagellar protein trafficking [47]. The bald 
phenotype of our mutant, however, does not coincide with the short flagella phenotype 
of the known cep290 mutant. It is necessary to review the phenotype of our mutant to 
determine if it has a confirmed mutation in CEP290. CEP290 is highly studied and 
Figure 14. 10P61 may be a PF16 mutant. (A) A diagram shows the relative positioning of the primers used for mutant 
confirmation. (B) 10P61 does not have an intact PF16 fragment between PF16UP and PF16DP. 10P61 produces ~1200 bp 
fragment when amplifying with PF16UP and UP1_H. This data supports that 10P61 is a PF16 mutant. 
PF16UP 
PHyg3 cut with HindIII 
PF16DP 
UP1_H A 
B 
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already has a mutant available, so there was no desire to proceed with confirming this 
mutant.  
Future Aspirations  
 Now that we have established the methods necessary to efficiently identify 
mutants from the random insertional mutant screen, we can now build a library of 
interesting flagellar mutants. The goal is to identify as many mutants as possible, so that 
there will be many to choose from when forming a solid project. The most useful 
mutants for this project would be mutations in complex B proteins, preferably from the 
periphery, to add to the structural assembly and localization work that was done with the 
core proteins. Once these mutants are identified, they will first be backcrossed and 
confirmed using PCR, western blotting, and rescuing the phenotypes. The confirmed 
mutants will then be characterized similar to the characterization that was done for the 
core protein mutants, ift46, bld1, and ift88. First, an in-depth phenotypic analysis will be 
performed to determine the protein’s function in maintaining proper flagellar 
morphology. Sucrose density gradients will show if these peripheral proteins impact the 
assembly of the complex. Cycloheximide time-course treatments will reveal how these 
proteins affect the stabilities of other IFT and motor proteins. Lastly, immunofluorescent 
staining will indicate whether or not the protein is necessary for the correct localization 
of IFT to the transition zone to allow for initiation of ciliogenesis. Results from these 
assays will further expose the function of the complex B periphery and will be a great 
addition to the core complex protein study to create a more complete picture of how 
complex B works as a whole during the IFT process. 
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Materials and Methods 
Strains and Culture Conditions 
 Mutated strains were created using the wild type cc125 strain from the 
Chlamydomonas Center (http://www.chlamy.org). Cells were grown in a Conviron with 
continuous light and aeration at 22ºC. Strains were grown on solid Tris-acetate-
phosphate (TAP) plates supplemented with hygromycin when necessary for selection or 
liquid TAP media. 
Mutagenesis 
 Wild type cells were grown until density reached ~2x106 to 2x107 cells/ml (dark 
green). Cells were collected by gently spinning and were resuspended in autolysin and 
shaken until cells were able to completely lyse in 1% Triton. Cells were again harvested 
by gentle centrifugation and then resuspended in TAP media. Next, about 4 µg of DNA 
(linearized and purified) was transformed into the cells using the glass bead method. 
Cells were allowed to recover in the dark for 24 hours and were then collected with 
gentle centrifugation and resuspended in a small amount of TAP. They were transferred 
to a TAP plate with hygromycin for selection. Plates were exposed to light for 6-8 days 
and about 100 colonies formed for an efficient transformation. Each colony was picked 
and cultured for screening.  
 For the first sets of mutants, pHyg3 [48] plasmid DNA linearized with ScaI was 
transformed into the cells. More recent mutants were created by transforming a much 
smaller fragment containing the hygromycin resistance gene by digesting pHyg3 with 
 
 
48 
 
 
HindIII. New mutants will be transformed with a PCR product that contains only the 
hygromycin resistance gene, but lacks the promoter. 
Mutant Screening 
Mutants were grown in 15 mL of TAP media for two days or until light to 
medium green. They were then screened based on their ability to phototax by using a 
box in which test tubes of culture were incubated for 4 minutes so that only a slit of light 
shone through to the sample. The tubes were then observed to have a distinct green line 
where the slit of light was if they are phototaxis positive, and these strains were 
discarded. Phototaxis negative strains had no distinct line and either had media that was 
homogenously green or had cells sink to the bottom, making the bottom of the tube more 
green (Figure 10). If strains were bald, they tended to have cells that clumped and this 
was visible with the naked eye. All strains that could not swim toward the light were 
kept for further screening. 
Cells were then observed under a compound light microscope to determine if 
they had visible flagellar or motility abnormalities and were categorized based on 
phenotype. Lugol’s iodine was used to fix cells to observe the flagella of cells that were 
motile. 
Western blot analysis revealed whether or not there were differences in 
expression of IFT or motor proteins to further screen for strains likely to have mutations 
in IFT-related genes. For detailed methods used to perform western blots, see methods in 
Chapter II (page 16). Antibodies used were against Chlamydomonas reinhardtii IFT139 
[9], IFT80, IFT46 [27], and FLA10 [9]. 
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DNA Extraction 
 For a quick extraction of DNA from each of the mutants, the following protocol 
was followed:  
1. Scrape a small amount of Chlamydomonas reinhardtii cells from a fresh plate 
with a sterile yellow micropipette tip or toothpick and resuspend in 20 μl H2O in 
a microcentrifuge tube. 
2. Add 20 μl 100% ethanol  
3. Mix well by pipetting up and down  
4. Add 200 μl 5% Chelex solution*  
5. Boil for 10 minutes  
6. Centrifuge at room temperature for 10 mins  
7. Transfer the supernatant to a new tube to be used for PCR (use 1μl per PCR 
reaction)  
8. Store at -20ºC for short term or -80ºC for long term storage. 
 
*Chelex preparation: 5% (w/v) in H
2
O:   
1. 5g Chelex® 100 Resin, add ddH2O to 100 ml 
2. Mix well using heat and stir bar (will not become clear) 
3. Autoclave for 15 mins 
4. pH should be greater than 9 for best results 
 
Note:  Chelex is insoluble, so be sure to swirl well before each use to ensure that the 
concentration of beads is correct. 
 
RESDA PCR 
Methods used for RESDA PCR are based, with some slight adjustments, on the 
protocol given to our lab by Jason Brown from the Witman lab. Three degenerate  
 primers were used, and both ends of the insert were amplified so that each mutant had a 
total of six primary PCR reactions (Tables 2 and 3).  
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Table 2. RESDA Primary PCR Reaction 
Volume ( μl) Reagent 
0.5 10µM Linearized Plasmid Primer  
1.5 10µM Degenerate Primer 
2.5 5X Green GoTaq® Reaction Buffer (Promega)   
0.125 GoTaq® DNA Polymerase (Promega)  
0.2 10 mM dNTPs 
0.375 DMSO  
0.5 25 mM MgCl
2 
 
6.3 ddH
2
O 
0.5 Mutant DNA (about 50 ng/µl) 
Table 3. RESDA Primary PCR Program 
Step Temperature (ºC) Time (min) 
1 95 2 
2 94 1 
3 62 1 
4 72 2.5 
5 Repeat steps 2-4 4X  
6 94 1 
7 25 3 
8 72 (Ramp rate: 0.3ºC/s) 2.5 
9 94 .5 
10 68 1 
11 72 2.5 
12 94 .5 
13 68 1 
14 72 2.5 
15 94 .5 
16 44 1 
17 72 2.5 
18 Repeat steps 9-17 14X  
19 72 5 
20 Hold at 16 ∞ 
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A secondary PCR reaction was then used to increase the specificity of the 
primary RESDA PCR product (Tables 4 and 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primers 
The Q0 primer and degenerate primers with restriction enzyme sites and Q0 were 
based on methods in Gonzalez-Ballester, et al, 2005 [30]. DegAluI was not used. Primer 
sequences used for the ends of the inserts in mutants created using pHyg3 digested with 
Table 4. RESDA Secondary PCR Reaction 
Volume (µl) Reagent 
0.5 10µM Linearized Plasmid Primer  
0.5 10µM Degenerate Primer 
2.5 5X Green GoTaq® Reaction Buffer (Promega)   
0.125 GoTaq® DNA Polymerase (Promega)  
0.2 10 mM dNTPs 
0.375 DMSO  
0.5 25 mM MgCl
2 
 
7.3 ddH
2
O 
0.5 Mutant DNA (primary PCR product diluted 1:25) 
Table 5. RESDA Secondary PCR Program 
Step Temperature (ºC) Time (min) 
1 95 2 
2 95 .5 
3 60 .5 
4 72 3 
5 Repeat steps 2-4 34X  
6 72 10 
7 Hold at 16 ∞ 
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HindIII were DP3, DP4, UP1 (Labeled UP_1 in Fig. 14), and UP2 from methods in 
Matsuo, et al, 2008 [49]. All other primers were designed using Primer3 (Table 6). 
 
Table 6. Primers Designed for RESDA PCR 
5' end right primers of 
pHyg3 cut with ScaI 
Up3 ATT GCT ACA GGC ATC GTG GT 
Up4 GCA GAA GTG GTC CTG CAA CT 
Up5 TCG TCG TTT GGT ATG GCT TC 
3’ end left primers of 
pHyg3cut with ScaI 
Dwn1 GCG CGG AAC CCC TAT TTG TTT A 
Dwn2 CCG CTC ATG AGA CAA TAA CCC TGA 
Primer to check for 
specificity of Up primers 
SpecU CAT GGG GGA TCA TGT AAC TC 
SpecU2 GCG GCC AAC TTA CTT CTG AC 
Other primers used  
 
Dwn3 GCC TGA TGC GGT ATT TTC TC 
IFT80F GTC AGC ACT CTG GAC GCA TA 
IFT80U GAC TTG ATG ACC ACG TTG GA 
IFT80D GTA CTC CAC CCA GCA CAC CT 
PF16UP GAA CAT GTT GCT GGC ACT TAG TCA CG 
PF16DP GGC GGT GGC GCT TTT GAG GTG G 
  
 
Sequencing 
Standard sequencing was performed by Eurofins Scientific. Phytozome v8.0 
from www.chlamy.org, NCBI BLAST, and Sequencher software were used for sequence 
analysis and identification of the disrupted gene.
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 CHAPTER V 
SUMMARY AND CONCLUSIONS 
 
 
 This study dissected the roles that IFT B proteins play on the stability, assembly, 
and localization of complex B. Sucrose density gradients and cycloheximide time-course 
treatments revealed that IFT52 is required for the stability and assembly of the core 
complex B (Figs. 4E and 3D, E), while IFT46 is not required for the assembly of the 
core (Fig. 3B) but is necessary to maintain stability of the complex (Fig. 4D). This 
explains why bld1is unable to perform ciliogenesis having a bald phenotype (Fig. 2), yet 
ift46 can produce flagella but they are severely shortened (Fig. 2) due to the complex’s 
lack of stability and fast turnover rate. IFT88, although a part of the core complex B, is 
necessary for neither the assembly nor the stability of complex B (Figs. 3C and 4C). 
Sucrose density gradients showed that in ift88 all core proteins cosedimented to form an 
intact, but slightly smaller complex (Fig. 3C), showing that IFT88 is not necessary to 
build the core but is probably required to bind peripheral proteins to the core. Ift88’s lack 
of flagella can be explained by the immunofluorescent stains that show IFT particle B 
fails to localize to the apical end of the basal body. This means that even though the core 
complex B is intact, it is missing a component necessary to localize to the initiation site 
for ciliogenesis, causing a bald phenotype. It is yet to be determined whether it is IFT80 
itself, or if it is one of the proteins that is bridged by IFT80 to the core complex B, that is 
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essential for the proper localization of complex B. Null mutants, RNAi, or microRNA 
knockdowns of peripheral proteins would help answer this question. The results of this 
study are explained by a model in which complex B is sequentially assembled, by first 
assembling the core which then binds to peripheral proteins and is next localized to the 
apical end of the basal body to initiate ciliogenesis (Fig. 8). 
 Little is known about the functions or interactions of peripheral proteins. Yeast 
two-hybrid analysis will be used to further investigate protein-protein interactions 
between core and peripheral proteins and among peripheral proteins. This will build on 
our knowledge of the architecture of complex B and how peripheral proteins interact 
with the core to permit IFT to take place in order to build flagella. 
 In an attempt to obtain new null mutants for peripheral IFT B proteins, random 
insertional mutagenesis was employed. To screen these for IFT mutants, only phototaxis 
negative mutants with defective flagella were investigated. RESDA PCR is proving to be 
useful in identifying the disrupted genes in these mutants. So far, five interesting 
flagella-related mutants have been identified, three of these being strains with disrupted 
IFT80, PF16, and CEP290. However, all of these genes already have mutants available 
to the scientific community, so they have not been confirmed or pursued. RESDA will 
be continued on our growing library of mutants in hopes that many more IFT mutants, 
preferably one null for an IFT B peripheral protein, will be identified. 
 Once novel mutants are discovered through the screening process, they will be 
backcrossed and confirmed by rescuing their phenotypes. Once the mutation is 
confirmed, we will engage in an in-depth phenotypic analysis. Cells will be examined in 
 
 
55 
 
 
detail microscopically to determine the morphology of the strain. Sucrose density 
gradients and cycloheximide treatments will show the protein’s effect on assembly and 
stability, respectively, of complex B. Immunofluorescent staining will show if the 
mutation causes a defect in localization patterns of IFT particles. In mutants that still 
have flagella, it may be useful to investigate if there is a disruption in important flagella-
related pathways such as the hedgehog signaling pathway. It is important to continue this 
mutant screen through RESDA PCR because novel mutants will be great tools to build 
our continually growing knowledge of the IFT process and its role in ciliogenesis. 
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